hydroxyurea has been researched along with Myelodysplastic-Myeloproliferative Diseases in 3 studies
Myelodysplastic-Myeloproliferative Diseases: Clonal myeloid disorders that possess both dysplastic and proliferative features but are not properly classified as either MYELODYSPLASTIC SYNDROMES or MYELOPROLIFERATIVE DISORDERS.
Excerpt | Relevance | Reference |
---|---|---|
"Secondary thrombocytosis is a frequent secondary finding in childhood infection and inflammation." | 2.72 | Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management. ( Cario, H; Duffert, CM; Knöfler, R; Kulozik, AE; Stockklausner, C; Streif, W, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Mykytiv, V | 1 |
Alnajjar, K | 1 |
Stockklausner, C | 1 |
Duffert, CM | 1 |
Cario, H | 1 |
Knöfler, R | 1 |
Streif, W | 1 |
Kulozik, AE | 1 |
Curto-Garcia, N | 1 |
Harrison, CN | 1 |
1 review available for hydroxyurea and Myelodysplastic-Myeloproliferative Diseases
Article | Year |
---|---|
Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management.
Topics: Adolescent; Adult; Age of Onset; Algorithms; Anticoagulants; Calreticulin; Child; Disease Management | 2021 |
2 other studies available for hydroxyurea and Myelodysplastic-Myeloproliferative Diseases
Article | Year |
---|---|
Leukostasis as a result of rapidly progressive granulocytosis in a patient diagnosed with MDS/MPN-U.
Topics: Aged; Bone Marrow; Fatal Outcome; Hematologic Neoplasms; Humans; Hydroxyurea; Leukostasis; Male; Mye | 2019 |
An updated review of the JAK1/2 inhibitor (ruxolitinib) in the Philadelphia-negative myeloproliferative neoplasms.
Topics: Aged; Animals; Blood Cell Count; Clinical Trials, Phase III as Topic; Disease Models, Animal; Diseas | 2018 |